New York State Common Retirement Fund Gemini Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$1.22 - $1.73 $1,220 - $1,730
-1,000 Reduced 83.26%
201 $0
Q1 2022

May 05, 2022
SELL
$1.29 - $3.08 $18 - $43
-14 Reduced 1.15%
1,201 $2,000
Q3 2021

Nov 02, 2021
SELL
$3.3 - $6.32 $57,700 - $110,505
-17,485 Reduced 93.5%
1,215 $5,000
Q2 2021

Aug 02, 2021
BUY
$6.32 - $14.02 $118,184 - $262,174
18,700 New
18,700 $121,000

Others Institutions Holding GMTX

# of Institutions
1
Shares Held
2.44M
Call Options Held
0
Put Options Held
0
View Full List

About Gemini Therapeutics, Inc.

GMTX Quotes by TradingView
  • Ticker GMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,244,500
  • Market Cap $1.05B
  • Description
  • Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...
More about GMTX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email